搜尋結果 "#bevacizumab"

動態

查看更多結果

Mary Grace N. Tamio shared news

在 September 06 2024 at 09:32 PM 已編輯

Secondary spontaneous pneumothorax during chemotherapy with bevacizumab for cervical cancer: a case report and literature review

#pneumothorax #chemotherapy #bevacizumab #cervicalcancer #journals #articles

More info | ⬇️

Secondary spontaneous pneumothorax during chemotherapy with bevacizumab for cervical cancer: a case report and literature review
Secondary spontaneous pneumothorax (SSP) due to bevacizumab has been reported in other malignancies but not in cervical ca...
0 0 0 0 0 0 0

留言

Like

分享
Mary Grace N. Tamio shared news

在 September 05 2023 at 07:22 PM 已編輯

Bevacizumab-induced arrhythmia in a patient with lung adenocarcinoma: A case report

#bevacizumab #arrhythmia #lungadenocarcinoma #journals #articles

More info | ⬇️

Bevacizumab-induced arrhythmia in a patient with lung adenocarcinoma: A case report
Rationale: Cardiotoxicity is an important side effect of vascular endothelial growth factor inhib
0 0 0 0 0 0 0

留言

Like

分享
Mary Grace N. Tamio shared news

在 June 10 2023 at 12:11 AM 已編輯

The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis

#bevacizumab #cetuximab #colorectalcancer #journals #articles

More info | ⬇️

Author Correction to: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis
Author Correction: International Journal of Clinical Pharmacy (2022) 44:...
0 0 0 0 0 0 0

留言

Like

分享
Mary Grace N. Tamio

在 August 21 2022 at 09:55 PM 已編輯

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomised controlled trials

#erlotinib #bevacizumab #EGFR #lungcancer #journals #articles

For more information | ⬇️
https://social.cn1699.com/livenewss/news/177883

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomised controlled trials | CN1699 Social
The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
0 0 0 0 0 0 0

留言

Like

分享
Mary Grace N. Tamio

在 July 11 2021 at 08:27 PM 已編輯

Early Response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria

#atezolizumab #bevacizumab #hepatocellularcarcinoma #IMbrave150

For more information |⬇️
https://social.cn1699.com/livenewss/news/87871
0 0 0 0 0 0 0

留言

Like

分享

搜尋過濾器

搜尋結果 "#bevacizumab"

動態